Huehls, Amelia M <br/><br/>
Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combination.  [electronic resource] 

 -  Molecular pharmacology  Oct 2012 
 - 767-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0111 
<br/><br/><label>Standard No.: </label>10.1124/mol.112.080614  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Ataxia Telangiectasia Mutated Proteins<br/>Benzimidazoles--pharmacology<br/>Cell Cycle Checkpoints<br/>Cell Cycle Proteins--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2<br/>DNA Damage<br/>DNA Repair<br/>Drug Synergism<br/>Enzyme Activation<br/>Female<br/>Floxuridine--pharmacology<br/>Homologous Recombination<br/>Humans<br/>Ovarian Neoplasms--pathology<br/>PTEN Phosphohydrolase--genetics<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--metabolism<br/>Signal Transduction